Standout Papers
- Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer (2004)
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer (1992)
- Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. (1993)
- The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen (1992)
Immediate Impact
15 by Nobel laureates 6 from Science/Nature 83 standout
Citing Papers
Prostate cancer
2021 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Works of Mitchell C. Benson being referenced
A single‐institution experience with induction and maintenance intravesical docetaxel in the management of non‐muscle‐invasive bladder cancer refractory to bacille Calmette‐Guérin therapy
2009
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mitchell C. Benson | 8505 | 3045 | 3887 | 267 | 13.1k | |
| Jean B. deKernion | 8720 | 3103 | 3981 | 218 | 12.9k | |
| Paul F. Schellhammer | 9270 | 3896 | 3231 | 268 | 17.2k | |
| Ganesh V. Raj | 5635 | 3131 | 3950 | 194 | 11.2k | |
| Patricia Troncoso | 7842 | 1670 | 3819 | 250 | 13.5k | |
| Markus A. Kuczyk | 6925 | 3153 | 5135 | 277 | 11.0k | |
| Isabell A. Sesterhenn | 5454 | 2956 | 4134 | 210 | 10.9k | |
| Kurt Miller | 8902 | 2095 | 4529 | 350 | 14.4k | |
| Axel S. Merseburger | 9097 | 3862 | 5606 | 408 | 13.5k | |
| Gerald P. Murphy | 5789 | 2107 | 1993 | 312 | 10.6k | |
| Brett Delahunt | 10503 | 2905 | 5768 | 295 | 13.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...